Covid-19 is likely to increase the burden of atherosclerotic cardiovascular disease in Kenya. BLOOD CLOTTINGCovid-19 has been known to cause clotting of blood (thrombosis) even in the heart, he said. According to the study, Covid-19 and cardiovascular disease share some pathological features and risk factors. This has likely contributed to the high mortality in patients with Covid-19 pneumonia, the society explains. According to Dr Gikonyo, Covid-19 patients with such heart conditions are being treated with blood thinners like aspirin and warfarin to stop the clotting.

Source: Daily Nation July 30, 2020 10:41 UTC